Add Company
Join Now

Arkana Laboratories Revenue and Competitors

License our Company Data API

Location

N/A

Total Funding

Medical Offices

Industry

Estimated Revenue & Valuation

  • Arkana Laboratories's estimated annual revenue is currently $28.9M per year.(i)
  • Arkana Laboratories's estimated revenue per employee is $270,000

Employee Data

  • Arkana Laboratories has 107 Employees.(i)
  • Arkana Laboratories grew their employee count by 0% last year.

Arkana Laboratories's People

NameTitleEmail/Phone
1
Chief Marketing OfficerReveal Email/Phone
2
Director Information TechnologyReveal Email/Phone
3
Director Laboratory ServicesReveal Email/Phone
4
Renal Pathologist and Director ResearchReveal Email/Phone
5
Chief Operating OfficerReveal Email/Phone
6
Director, Transplant Translational Research & Multiplex Imaging CenterReveal Email/Phone
7
Director, Sponsored Projects AdministrationReveal Email/Phone
8
Chief People OfficerReveal Email/Phone
9
Marketing ManagerReveal Email/Phone
10
Materials Management ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$36.5M1350%N/AN/A
#2
$18M7410%N/AN/A
#3
$54.6M1847%N/AN/A
#4
$8.6M408%N/AN/A
#5
$45.7M154N/AN/AN/A
#6
$145.5M4315%N/AN/A
#7
$28.9M1070%N/AN/A
#8
$10.8M500%N/AN/A
#9
$13.1M5410%N/AN/A
#10
$36.5M1356%N/AN/A
Add Company

What Is Arkana Laboratories?

Arkana Laboratories is a center for esoteric pathology focused on one thing: improving care for patients. Led by Director Patrick D. Walker, M.D., our 20 fellowship-trained pathologists have decades of experience interpreting biopsies. Arkana is committed to providing doctors with the highest quality, clinico-pathologic discussion possible. We recognize that in order to best serve the needs of our clinicians we must work together with them, not just as a lab, but as an extension of their practice. It is our goal to help equip doctors with the results they need to deliver the most effective patient care possible. As pathologists, we recognize that the longest period in a patient's life is the timeframe between the day he/she has a biopsy and the day the result arrives.

keywords:N/A

N/A

Total Funding

107

Number of Employees

$28.9M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Arkana Laboratories News

2022-03-22 - FDA Rejects Reata's Application for Chronic Kidney Disease ...

... (bardoxolone) for the treatment of patients with chronic kidney disease (CKD) caused by Alport syndrome (pictured).[Arkana Laboratories].

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$23.5M1076%N/A
#2
$31M1076%N/A
#3
$29.7M11012%N/A
#4
$75M1110%$9.7M
#5
$36.4M112-36%N/A